Drug Shortage Report for CIPRO XL
Report ID | 30093 |
Drug Identification Number | 02251787 |
Brand name | CIPRO XL |
Common or Proper name | Ciprofloxacin Hydrochloride and Ciprofloxacin Extended Release |
Company Name | BAYER INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CIPROFLOXACIN |
Strength(s) | 1000MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 50 |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-11-27 |
Actual start date | |
Estimated end date | 2018-04-16 |
Actual end date | 2018-04-09 |
Shortage status | Resolved |
Updated date | 2018-04-10 |
Company comments | Product is now available in the market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-11-22 | English | Compare |
v2 | 2017-11-22 | French | Compare |
v3 | 2017-11-28 | English | Compare |
v4 | 2018-01-11 | English | Compare |
v5 | 2018-01-11 | French | Compare |
v6 | 2018-02-28 | English | Compare |
v7 | 2018-02-28 | French | Compare |
v8 | 2018-04-09 | English | Compare |
v9 | 2018-04-09 | French | Compare |
v10 | 2018-04-10 | English | Compare |
Showing 1 to 10 of 10